Rheumatoid Arthritis

BI wins antibody contract

BI wins antibody contract

German biotechnology company TeGenero has signed up Boehringer
Ingelheim to make clinical trials of its antibody drug in a move
that reflects an emerging trend in the contract manufacturing
sector.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers